Skip to main content
P

Perivision

Perivision develops the VisionOne™ platform, which utilizes virtual reality, artificial intelligence, and cloud computing to perform rapid and accurate visual field tests for glaucoma diagnosis and monitoring. This technology enables eye doctors to configure tests on portable VR headsets and analyze results through a cloud-based platform, enhancing clinical decision-making and patient care.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Glaucoma, a leading cause of irreversible blindness, often goes undetected due to limitations in specialized eye care infrastructure and the silent progression of the disease. Traditional visual field tests, essential for glaucoma diagnosis and monitoring, can be lengthy, uncomfortable, and subjective, leading to unreliable results and infrequent testing.

Solution

PeriVision offers VisionOne™, a virtual-reality (VR) based platform that leverages artificial intelligence (AI) and cloud computing to transform visual field testing for glaucoma. The portable VR headset allows for rapid and accurate visual field tests, reducing examination times by up to 70% compared to traditional perimetry. AI algorithms optimize the tests, automate assistance, and control quality, providing valuable insights for clinical decisions. The cloud-based platform enables eye doctors to easily configure eye tests on the VR headsets and subsequently analyze the results, enhancing clinical decision-making and patient care.

Target Audience

The primary target audience includes ophthalmologists, optometrists, and eye care professionals seeking efficient, accurate, and patient-friendly solutions for glaucoma diagnosis and monitoring.

Features

  • Portable VR headset for convenient and accessible visual field testing
  • AI-powered algorithms for optimized and automated test procedures
  • Cloud-based platform for remote configuration and analysis of test results
  • Patented machine learning algorithm to reduce examination times while maintaining accuracy
  • Eye-tracking technology to ensure patient fixation and test reliability
  • Integration of structural and functional data for comprehensive glaucoma assessment
This profile is AI-generated and may contain inaccuracies.